Rallybio Corp

RLYB

Rallybio Corp

RLYB

Insider Sentiment (TTM):

Last Purchase:2026-05-19Last Sale:2026-02-23Shares Purchased (TTM):46,401Shares Sold (TTM):789

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,653,487Shares Outstanding:5,688,584Institutional Ownership Pct.:81.80%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	93	41	31	32	9	15	14	25	17	19	24	19
Marketable Securities Current	0	5	23	27	36	40	52	50	72	75	85	102
Prepaid Expense And Other Assets Current	4	7	7	7	5	3	2	3	3	4	5	11
Assets Current	97	53	61	67	50	57	68	78	91	99	115	132
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Investments In Affiliates Subsidiaries Associates …	-	-	-	-	1	0	0	0	1	0	0	0
Other Assets Noncurrent	1	1	1	1	-	-	0	-	-	-	-	-
Assets	98	54	62	68	51	58	68	79	92	99	116	133
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	0	0	0	0	0	1	1	0	1	0
Accrued Liabilities Current	1	3	4	4	4	3	5	6	10	9	8	9
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Contract With Customer Liability Current	0	0	0	0	1	1	1	1	1	-	0	-
Liabilities Current	4	4	4	5	5	4	6	8	12	10	9	9
Operating Lease Liability Noncurrent	0	0	0	0	-	-	0	0	0	0	0	0
Contract With Customer Liability Noncurrent	-	-	0	0	0	0	0	-	0	-	0	-
Liabilities	4	4	4	5	5	4	6	8	12	10	9	10
Stockholders Equity Inclu…
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	361	361	360	359	358	356	355	353	351	343	341	339
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	-0	-0	0	-0
Retained Earnings Accumulated Deficit	-267	-310	-302	-296	-312	-302	-293	-282	-271	-254	-235	-215
Stockholders Equity	94	50	58	63	46	54	62	71	80	89	106	124
Liabilities And Stockholders Equity	98	54	62	68	51	58	68	79	92	99	116	133
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	5	5	5	5	5	5	5	5	5	5	5	5
Shares Outstanding	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	11.15%	10.21%	11.01%	-	-	-	-	-	-	-	-	-
2025	5.46%	13.65%	70.31%	5.09%	7.63%	19.37%	1.88%	7.67%	5.16%	-10.31%	52.82%	69.50%
2024	-12.11%	-29.47%	-28.42%	-3.36%	-7.14%	-13.45%	18.18%	-7.68%	-11.11%	-31.40%	-51.68%	-52.90%
2023	-	-	-	2.46%	-36.17%	-23.86%	-26.64%	-21.38%	-54.28%	-2.98%	8.93%	-0.60%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	27.26	12.92	14.50	14.74	9.98	14.68	10.87	9.55	7.52	9.77	12.39	14.08
Quick Ratio	26.03	11.30	12.96	13.13	9.08	13.94	10.50	9.18	7.29	9.34	11.87	12.91
Working Capital	93.69M	49.35M	57.03M	62.11M	45.23M	53.47M	61.60M	70.04M	79.28M	88.46M	105.53M	123.02M
Leverage & Debt
Debt to Equity	0.04	0.08	0.07	0.07	0.11	0.07	0.10	0.12	0.16	0.11	0.09	0.08
Debt Ratio	0.04	0.08	0.07	0.07	0.10	0.07	0.09	0.10	0.13	0.10	0.08	0.07
Efficiency & Turnover
Asset Turnover TTM	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	7.86	-1.37	-1.59	-2.52	-7.43	-8.61	-10.61	-12.01	-13.39	-14.97	-14.75	-13.92
Free Cash Flow Per Share TTM	4.30	-4.85	-5.30	-4.40	-5.67	-7.87	-9.05	-9.16	-9.79	-11.18	-11.92	-12.61
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-4,291.49%	-3,744.41%	-3,853.61%	-5,676.56%	-5,703.15%	-5,940.92%	-9,511.95%	-11,705.69%	-25,851.84%	-	-	-
Net Profit Margin TTM	7,051.24%	-911.07%	-1,046.39%	-2,102.37%	-5,473.32%	-5,682.19%	-9,084.12%	-11,199.50%	-24,709.36%	-	-	-
Growth Metrics
Net Revenue Growth (1Y)	-15.11%	1.18%	34.91%	12.71%	154.52%	-	-	-	-	-	-	-
Net Income Growth (1Y)	-209.36%	-83.78%	-84.46%	-78.84%	-43.62%	-36.83%	-22.52%	-5.04%	4.76%	9.79%	11.87%	-7.38%
EPS Growth (1Y)	-207.56%	-84.04%	-84.97%	-79.06%	-44.52%	-42.48%	-28.03%	-13.69%	-4.17%	8.38%	-11.99%	-29.67%
Valuation Metrics
P/E TTM	2.00	-6.53	-3.44	-1.59	-0.36	-0.61	-0.72	-0.78	-0.80	-0.99	-1.30	-1.94
P/B TTM	0.96	1.01	0.53	0.36	0.33	0.54	0.68	0.74	0.74	0.85	0.91	1.11
P/S TTM	141.15	59.47	36.01	33.36	19.92	34.59	65.73	87.25	197.76	-	-	-
Market Cap	91.19M	51.03M	30.89M	22.48M	15.16M	29.33M	41.80M	52.17M	59.13M	75.43M	96.67M	136.59M
Enterprise Value	-1.66M	9.73M	-480.02K	-9.64M	5.71M	14.55M	27.90M	26.85M	42.46M	56.13M	72.18M	117.43M
Calculated Values
Free Cash Flow TTM	24.49M	-27.59M	-29.81M	-24.79M	-31.79M	-44.03M	-49.28M	-51.08M	-54.00M	-56.97M	-60.28M	-63.88M
Net Debt	-92.85M	-41.30M	-31.37M	-32.12M	-9.45M	-14.78M	-13.90M	-25.32M	-16.67M	-19.30M	-24.49M	-19.16M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-19Purchase

Owner: Adar1, Capital Management…

Title: -

Shares: 10,200

Price/Share: $13.89

Value: $141,678.00

Shares Owned: 926,352

Relationship: TenPercentOwner

Ownership: Indirect

2026-05-15Purchase

Owner: Schneeberger, Daniel, Ada…

Title: -

Shares: 300

Price/Share: $13.88

Value: $4,164.00

Shares Owned: 910,143

Relationship: TenPercentOwner

Ownership: Indirect

2026-05-12Purchase

Owner: Adar1, Capital Management…

Title: -

Shares: 800

Price/Share: $13.83

Value: $11,064.00

Shares Owned: 830,584

Relationship: TenPercentOwner

Ownership: Indirect

2026-05-05Purchase

Owner: Schneeberger, Daniel, Ada…

Title: -

Shares: 35,101

Price/Share: $14.00

Value: $491,414.00

Shares Owned: 779,784

Relationship: TenPercentOwner

Ownership: Indirect

2026-02-23Sale

Owner: Lieber, Jonathan I

Title: Chief Financial Officer

Shares: 789

Price/Share: $5.06

Value: $3,992.34

Shares Owned: 4,115

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-19	Adar1, Capital Management…	TenPercentOwner	-	Indirect	Purchase	10,200	13.89	$141,678.00	926,352	4
2026-05-15	Schneeberger, Daniel, Ada…	TenPercentOwner	-	Indirect	Purchase	300	13.88	$4,164.00	910,143	4
2026-05-12	Adar1, Capital Management…	TenPercentOwner	-	Indirect	Purchase	800	13.83	$11,064.00	830,584	4
2026-05-05	Schneeberger, Daniel, Ada…	TenPercentOwner	-	Indirect	Purchase	35,101	14.00	$491,414.00	779,784	4
2026-02-23	Lieber, Jonathan I	Officer	Chief Financial Officer	Direct	Sale	789	5.06	$3,992.34	4,115	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

81.80%

Inst. Shares: 4,653,487

Shares Outstanding: 5,688,584

2025-12-31

Inst. Shares: 24,770,015

Shares Outstanding: 5,629,370

2025-09-30

Inst. Shares: 24,830,495

Shares Outstanding: 5,632,324

2025-06-30

Inst. Shares: 31,000,919

Shares Outstanding: 5,605,143

2025-03-31

Inst. Shares: 31,895,727

Shares Outstanding: 5,597,528

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,653,487	5,688,584	81.80%
2025-12-31	24,770,015	5,629,370	-
2025-09-30	24,830,495	5,632,324	-
2025-06-30	31,000,919	5,605,143	-
2025-03-31	31,895,727	5,597,528	-
2024-12-31	31,568,144	5,443,332	-
2024-09-30	31,107,219	5,574,153	-
2024-06-30	31,495,228	5,516,007	-
2024-03-31	29,610,966	5,096,702	-
2023-12-31	31,662,553	5,055,924	-
2023-09-30	31,172,651	5,066,437	-
2023-06-30	33,217,715	5,045,488	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Rallybio Corp (RLYB) — SEC Financial Statements & Analysis

Rallybio Corp (RLYB) is a pharmaceutical preparations company, incorporated in DE. Rallybio Corp trades on Nasdaq as: RLYB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Rallybio Corp reported a -15.11% year-over-year revenue growth, a Debt-to-Equity ratio of 0.04x, a Price-to-Sales (P/S) ratio of 141.15x (TTM), a Price-to-Book (P/B) ratio of 0.96x (TTM), at a market cap of $91.19M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -15.11%
Debt To Equity: 0.04x
P/S TTM: 141.15x
P/B TTM: 0.96x
Market Cap: $91.19M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Rallybio Corp in?

Rallybio Corp (RLYB) operates in the Pharmaceutical Preparations industry.

What is RLYB's market cap?

Rallybio Corp (RLYB) has a market capitalization of $91.19M as of 2026-06-30.

What is RLYB's P/E ratio?

Rallybio Corp (RLYB)'s trailing twelve month P/E ratio is 2.00x as of 2026-06-30.

What exchange does RLYB trade on?

Rallybio Corp (RLYB) trades on the Nasdaq.

Where is Rallybio Corp incorporated?

Rallybio Corp is incorporated in DE.

Rallybio Corp

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Rallybio Corp (RLYB) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Rallybio Corp (RLYB) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.